LAUREN MACHA: Open Payments
NPI 1821753260 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,783 in 156 payments from 20 companies in 2025. Trend: 2023 $967 · 2024 $3,229 · 2025 $3,783
Food & beverage: $3,597Education: $166Travel & lodging: $20
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $565 |
| Regeneron Healthcare Solutions, Inc. | 15 | $483 |
| ABBVIE INC. | 18 | $425 |
| Arcutis Biotherapeutics, Inc. | 12 | $402 |
| UCB, Inc. | 11 | $353 |
| Galderma Laboratories, L.P. | 23 | $263 |
| Botanix SB Inc | 6 | $259 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 10 | $216 |
| Novartis Pharmaceuticals Corporation | 7 | $154 |
| PFIZER INC. | 2 | $114 |
Products named: TREMFYA, DUPIXENT, Zoryve, Bimzelx, SOFDRA, Cabtreo, NEMLUVIO, BOTOX.
Industry payments across TX — which companies pay providers there.
